Organization
Arog Pharmaceuticals
6 clinical trials
Clinical trial
A Phase II Study of Crenolanib Besylate Maintenance Following Allogeneic Stem Cell Transplantation in Patients With FLT3-positive Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2022-05-01
Clinical trial
Pilot Study of Crenolanib Combined With Standard Salvage Chmetherapy in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2018-02-01
Clinical trial
A Phase II Study of Crenolanib Besylate in Subjects With Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2014-08-01
Clinical trial
Phase I-II Study of Crenolanib Combined With Standard Salvage Chemotherapy, and Crenolanib Combined With 5-Azacitidine in Acute Myeloid Leukemia Patients With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2020-07-15
Clinical trial
A Safety and Tolerability Trial of Crenolanib and Chemotherapy With Cytarabine and Anthracyclines in Patients With Newly Diagnosed Acute Myeloid Leukemia With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-12-01
Clinical trial
A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-04-01